Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Gallagher

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Virology|June 26, 2015
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type SpecificTina M Cairns, Zhen-Yu Huang, John R Gallagher, et al.
Mbio|August 24, 2017
The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the MembraneJuan Fontana, Doina Atanasiu, Wan Ting Saw, et al.
Virus Research|March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Journal of Virology|May 3, 2014
Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein DJ Charles Whitbeck, Zhen-Yu Huang, Tina M Cairns, et al.
Nature Communications|March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodiesMallory L Myers, John R Gallagher, Alexander J Kim, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Plos Pathogens|August 28, 2023
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopesDustin M McCraw, Mallory L Myers, Neetu M Gulati, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Virology|June 26, 2015
Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type SpecificTina M Cairns, Zhen-Yu Huang, John R Gallagher, et al.
Mbio|August 24, 2017
The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the MembraneJuan Fontana, Doina Atanasiu, Wan Ting Saw, et al.
Virus Research|March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric statesMallory L Myers, Michael T Conlon, John R Gallagher, et al.
Journal of Virology|May 3, 2014
Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein DJ Charles Whitbeck, Zhen-Yu Huang, Tina M Cairns, et al.
Nature Communications|March 30, 2023
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodiesMallory L Myers, John R Gallagher, Alexander J Kim, et al.
Frontiers in Immunology|October 17, 2022
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Frontiers in Immunology|September 29, 2023
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virusMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2024
Structure-guided assembly of an influenza spike nanobicelle vaccine provides pan H1 intranasal protectionMallory L Myers, John R Gallagher, De'Marcus D Woolfork, et al.
Plos Pathogens|August 28, 2023
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopesDustin M McCraw, Mallory L Myers, Neetu M Gulati, et al.
Pageof 4